Researchers at the Wistar Institute and Temple University have identified a metabolic target that may help overcome chemotherapy resistance in ovarian cancer. This discovery could potentially restore sensitivity to chemotherapy in ovarian cancer. The details of the method or application of this target are not specified, but it appears to involve targeting a metabolic mechanism.